Quick answers
- What is Prismasol Bgk2/3.5?
- Prismasol Bgk2/3.5 is a brand name of Calcium chloride, magnesium chloride, dextrose anhydrous, lactic acid, sodium chloride, sodium bicarbonate, and potassium chloride, a prescription medicine. The FDA NDC Directory lists 1 Prismasol Bgk2/3.5 product in 1 strength and form.
- Who makes Prismasol Bgk2/3.5?
- Vantive US Hlthcare holds the FDA application for Prismasol Bgk2/3.5 (NDA021703, approved October 25, 2006).
- Is there a generic or store brand of Prismasol Bgk2/3.5?
- Other products of Calcium chloride, magnesium chloride, dextrose anhydrous, lactic acid, sodium chloride, sodium bicarbonate, and potassium chloride are listed with the FDA, but none in exactly the same strength and form as a Prismasol Bgk2/3.5 product.
- Has Prismasol Bgk2/3.5 been recalled?
- No recall linked to Prismasol Bgk2/3.5 products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Prismasol Bgk2/3.5 is
Each Prismasol Bgk2/3.5 product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Calcium chloride, magnesium chloride, dextrose anhydrous, lactic acid, sodium chloride, sodium bicarbonate, and potassium chloride · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| anhydrous dextrose 20 g/L · calcium chloride 5.15 g/L · lactic acid 5.4 g/L · magnesium chloride 2.03 g/L · potassium chloride 0.157 g/L · sodium bicarbonate 3.09 g/L · sodium chloride 6.46 g/L injection (intravenous) | Prismasol Bgk2/3.5 | None listed | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Calcium chloride, magnesium chloride, dextrose anhydrous, lactic acid, sodium chloride, sodium bicarbonate, and potassium chloride →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA021703 | Vantive US Hlthcare | October 25, 2006 | 1 |
Companies that list Prismasol Bgk2/3.5
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Prismasol Bgk2/3.5 products.
- Vantive US Healthcare LLC1 product
Recalls
No recall linked to Prismasol Bgk2/3.5 products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.